Does MUROMONAB-CD3 Cause Post transplant lymphoproliferative disorder? 22 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 22 reports of Post transplant lymphoproliferative disorder have been filed in association with MUROMONAB-CD3. This represents 19.3% of all adverse event reports for MUROMONAB-CD3.
22
Reports of Post transplant lymphoproliferative disorder with MUROMONAB-CD3
19.3%
of all MUROMONAB-CD3 reports
3
Deaths
14
Hospitalizations
How Dangerous Is Post transplant lymphoproliferative disorder From MUROMONAB-CD3?
Of the 22 reports, 3 (13.6%) resulted in death, 14 (63.6%) required hospitalization, and 2 (9.1%) were considered life-threatening.
Is Post transplant lymphoproliferative disorder Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for MUROMONAB-CD3. However, 22 reports have been filed with the FAERS database.
What Other Side Effects Does MUROMONAB-CD3 Cause?
Infection (16)
Cytomegalovirus infection (13)
Cytomegalovirus oesophagitis (10)
Drug resistance (10)
Duodenitis (10)
Gastritis (10)
Weight decreased (10)
Chest pain (9)
Cytomegalovirus chorioretinitis (9)
Cytomegalovirus infection reactivation (9)
What Other Drugs Cause Post transplant lymphoproliferative disorder?
TACROLIMUS (2,529)
MYCOPHENOLATE MOFETIL (1,762)
PREDNISONE (1,441)
CYCLOSPORINE (957)
PREDNISOLONE (772)
RITUXIMAB (719)
CYCLOPHOSPHAMIDE (667)
METHYLPREDNISOLONE (506)
LAPINE T-LYMPHOCYTE IMMUNE GLOBULIN (439)
MYCOPHENOLIC ACID (438)
Which MUROMONAB-CD3 Alternatives Have Lower Post transplant lymphoproliferative disorder Risk?
MUROMONAB-CD3 vs MYCOPHENOLATE
MUROMONAB-CD3 vs MYCOPHENOLATE MOFETIL
MUROMONAB-CD3 vs MYCOPHENOLATE MOFETIL\MYCOPHENOLATE MOFETIL
MUROMONAB-CD3 vs MYCOPHENOLIC ACID
MUROMONAB-CD3 vs MYFORTIC